Global Clinical Head (Pulmonologist)- Executive Director

Are you a clinical research expert ready for new opportunities? Would you like to play a pivotal role in the development of potential medicines? If you are passionate about being a medical leader for a cross-functional team in a group that drives action towards the improvement of global public health– join us! As Global Clinical Head (Executive Director) you will have a unique opportunity to further elevate the Infectious Disease Unit in one of the world’s most respected biopharmaceutical companies.  The role holds a significant development opportunity for the successful candidate whilst contributing to the positive journey that AstraZeneca is on. 

Accountabilities: 

The Global Clinical Head (GCH) will have overall clinical leadership of one or more global products in the Infectious Disease pipeline specifically related to the prevention of infections in patients with chronic respiratory diseases. The GCH is also responsible for medical/scientific strategies for the clinical components of the Target Product Profile (TPP), Clinical Development Plan (CDP), and regulatory documents (e.g., briefing documents, CTD/BLA, core labelling texts). Within the Clinical Project Team, the GCH has accountability for the clinical, scientific, and value content and delivery of the medical components for the program to time and quality. The GCH will be the team’s voice and representative on the Global Project Team that oversees the overall strategy of Infectious Disease Unit’s products. 

Essential Skills/Experience: 

• Graduate of a recognized school of medicine with an MD degree or equivalent with board-certification in pulmonology 

• Demonstrated clinical research expertise in Pulmonology (especially in COPD and bronchiectasis) 

• Pharma industry experience in clinical drug development for at least 10 years 

• Experience in early and late stage program development and trial conduct 

• Developed/delivered in parallel multiple complex and/or large studies (e.g., including but not limited to global, pivotal Phase 3 efficacy studies) 

• Demonstrated ability to lead the development of a program strategy (e.g., Clinical Development Plans) and be accountable for project plans, timelines, progress, and outcomes 

• Writing and delivery of global regulatory submissions (e.g., NDA/BLA submissions, benefit/risk assessment) and interacting with major Health Authorities (e.g., FDA, EMA, PMDA, CDE) 

• Demonstrated ability leading and motivating teams in a matrix environment 

• Demonstrat